CollPlant Biotechnologies Financials - Benzinga

CollPlant Biotechnologies Ltd

CLGNNASDAQ

Trade with Public

Trade with Public

$0.3580

0.068323.58%

At close: Aug 28, 5:00 PM EST

$0.3419

-0.0161-4.5%

After Hours: Aug 28, 7:59 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Compare Options Stock Report

CollPlant Biotechnologies Financials

CollPlant Biotechnologies (CLGN) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
CollPlant Biotechnologies Q1 Adj. EPS $(0.21) Misses $(0.19) Estimate, Sales $73.000K Miss $1.100M Estimate

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 110 percent decrease over losses of $(0.10) per

Benzinga Newsdesk

PRO
CollPlant Biotechnologies Q4 Adj. EPS $(0.25) Misses $(0.19) Estimate, Sales $60.000K Miss $1.524M Estimate

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.19) by 31.58 percent. This is a 16.67 percent increase over losses of $(0.30) per

Benzinga Newsdesk

PRO
CollPlant Biotechnologies Q4 Adj. EPS $(0.25) Misses $(0.19) Estimate, Sales $60.000K Miss $1.524M Estimate.

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.19) by 31.58 percent. This is a 16.67 percent increase over losses of $(0.30) per

Benzinga Newsdesk

Earnings Scheduled For March 26, 2026

Benzinga Insights

PRO
CollPlant Biotechnologies Q3 Adj. EPS $(0.25) Misses $0.15 Estimate, Sales $77.000K Miss $4.845M Estimate

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $0.15 by 261.29 percent. This is a 24.24 percent increase over losses of $(0.33) per

Benzinga Newsdesk

Earnings Scheduled For November 26, 2025

Benzinga Insights